Cheelcare Income Statement

Financials in millions CAD. Fiscal year is May - April.

Millions CAD. Fiscal year is May - Apr.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Oct '25 Oct 31, 2025	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023
Revenue	1.56	1.57	1.44	1.11
Revenue Growth (YoY)	8.27%	9.22%	29.47%	-
Cost of Revenue	0.85	0.77	0.67	0.53
Gross Profit	0.7	0.8	0.77	0.58
Selling, General & Admin	1.54	1.26	0.94	0.51
Research & Development	0.35	0.17	0.14	0.13
Operating Expenses	2.35	1.8	1.08	0.65
Operating Income	-1.64	-1.01	-0.31	-0.06
Interest Expense	-0.38	-0.28	-0.19	-0.16
Other Non Operating Income (Expenses)	-1.21	0.02	-0.04	0.09
Pretax Income	-3.23	-1.27	-0.54	-0.13
Net Income	-3.23	-1.27	-0.54	-0.13
Net Income to Common	-3.23	-1.27	-0.54	-0.13
Shares Outstanding (Basic)	9	3	3	-
Shares Outstanding (Diluted)	9	3	3	-
Shares Change (YoY)	239.50%	0.56%	-	-
EPS (Basic)	-0.36	-0.48	-0.20	-
EPS (Diluted)	-0.36	-0.48	-0.20	-
Free Cash Flow	-2.69	-0.51	-0.21	-0.03
Free Cash Flow Per Share	-0.30	-0.19	-0.08	-
Gross Margin	45.23%	50.68%	53.67%	52.67%
Operating Margin	-105.59%	-64.05%	-21.60%	-5.65%
Profit Margin	-207.85%	-80.90%	-37.63%	-11.39%
Free Cash Flow Margin	-172.73%	-32.18%	-14.80%	-2.69%
EBITDA	-1.51	-0.96	-0.31	-0.06
EBITDA Margin	-97.17%	-61.13%	-21.33%	-5.17%
D&A For EBITDA	0.13	0.05	0	0.01
EBIT	-1.64	-1.01	-0.31	-0.06
EBIT Margin	-105.59%	-64.05%	-21.60%	-5.65%
Revenue as Reported	-	-	-	1.11
Advertising Expenses	-	0.01	0.06	0.08

Source: S&P Capital IQ. Standard template. Financial Sources.